UltraTech Cement Ltd
ULTRACEMCOUltraTech Cement Ltd's earnings have outrun its stock. EPS grew +35.2% in a year against a −6.2% price move.
The sharpest disagreement: annual EPS moved +35.2% against a −6.2% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (12 weeks in) while the P/E sits at the 50th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +17.2% year on year, and 174% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
UltraTech Cement Ltd trades at ₹11,727, in a downtrend and 12 weeks into that stage. That is +0.1% against its own 200-day average. It sits at 47% of a 52-week range of ₹10,616 to ₹12,963. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (8 weeks and counting).
Today the stock is in a downtrend — week 12 of stage 4, confirmed. At ₹11,727 it trades +0.1% versus its 200-day average and sits at 47% of its 52-week range (₹10,616–₹12,963).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +323% while the NIFTY 500 moved +280% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (8 weeks and counting; last ahead the week of 2026-06-12) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 50th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
UltraTech Cement Ltd trades at 40.5× P/E, mid-range by its own standards (50th percentile). Its long-run median P/E is 40.5×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 40.5× is mid-range by its own standards (50th percentile), against a long-run median of 40.5× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +35.2% against a −6.2% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +9.8%/yr price move, ~+5.6%/yr came from earnings growth and ~+4.2 pp from the multiple (expanding); over 10y, of the +12.8%/yr price move, ~+11.7%/yr came from earnings growth and ~+1.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
UltraTech Cement Ltd reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 13.0% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +16.5% | +11.9% | +14.6% | +13.4% |
| Profit | +35.6% | +17.3% | +8.4% | +12.7% |
| EPS | +35.2% | +16.5% | +7.9% | +11.9% |
| Share price | −6.2% | +12.7% | +9.8% | +12.8% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
60.8/100 — rank 5 of 26 in Cement · 91% evidence confidence
UltraTech Cement Ltd scores 60.8 out of 100 against the 26 companies it is compared with in Cement, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.8 + 16.5 + 10.1 + 14.4 = 60.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
UltraTech Cement Ltd reported ₹24,648 Cr of revenue in the Jun 26 quarter, +15.9% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.4% a year. The last full year, FY26, came in at ₹88,512 Cr. The last four reported quarters add to ₹91,884 Cr.
UltraTech Cement Ltd reported ₹24,648 Cr of revenue in the Jun 26 quarter, +15.9% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.4% a year. The last full year, FY26, came in at ₹88,512 Cr. The last four reported quarters add to ₹91,884 Cr.
FY26 revenue came in at ₹88,512 Cr (+16.5% on the year), capping 10 years at 13.4% compound. The latest quarter (Jun 26) printed ₹24,648 Cr, +15.9% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +17.7% growth against the decade's 13.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +17.2% over the last 4 quarters against +13.0%/yr over the last 8 — accelerating; TTM profit +26.7% vs +12.2%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 20.0% this quarter (−1.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
UltraTech Cement Ltd's operating margin is 20.0% in the Jun 26 quarter, −1.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 17.0% to 26.0%. The current quarter sits inside that band.
UltraTech Cement Ltd's operating margin is 20.0% in the Jun 26 quarter, −1.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 17.0% to 26.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 20.0%, −1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 17.0%–26.0%.
🚨 Why the margin moved: operating margin went −0.4 pp year on year while gross margin went −0.3 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins slipped — did that reach the bottom line? Next: profit +17.2% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
UltraTech Cement Ltd earned ₹2,604 Cr of net profit in the Jun 26 quarter, +17.2% year on year. It is the 6th consecutive quarter of growth. Full-year FY26 profit was ₹8,188 Cr. The 10-year compound rate is 12.7%. That is 10.6% of the quarter's revenue. The same quarter a year earlier earned ₹2,221 Cr.
UltraTech Cement Ltd earned ₹2,604 Cr of net profit in the Jun 26 quarter, +17.2% year on year. It is the 6th consecutive quarter of growth. Full-year FY26 profit was ₹8,188 Cr. The 10-year compound rate is 12.7%. That is 10.6% of the quarter's revenue. The same quarter a year earlier earned ₹2,221 Cr.
Jun 26 profit was ₹2,604 Cr, +17.2% year on year — the 6th consecutive quarter of growth. On the full year, FY26 printed ₹8,188 Cr (+35.6%), and the 10-year compound rate is 12.7%.
Why profit moved: revenue contributed +15.9% and the margin −1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +35.1% vs revenue +17.7%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
→ Profit rose — but did the cash follow? Next: 174% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 174% of UltraTech Cement Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹15,316 Cr of operating cash against ₹8,188 Cr of profit. After ₹11,382 Cr of capital spending, ₹3,934 Cr was left as free cash.
FY26: operating cash of ₹15,316 Cr against reported profit of ₹8,188 Cr, leaving free cash of ₹3,934 Cr after ₹11,382 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 174% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 174%: the cash cycle stretched 19 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 4.7× depreciation over three years, so the next section's job is to check what that build-out is buying.
→ So follow the cash to where it goes. Next: ₹55,721 Cr of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
UltraTech Cement Ltd's cash conversion cycle runs 13 days in FY26, up from −6 days in FY21. Capital spending ran ₹55,721 Cr over the last 3 years. At FY26 sales of ₹88,512 Cr each day of that cycle holds about ₹242 Cr, so roughly ₹3,152 Cr sits inside the business at any moment.
FY26: debtors at 25 days, inventory at 206 days — roughly 6.8 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 13 days, looser than FY21's −6.
The full loop: cash goes out to suppliers and production on day 0; stock waits 206 days to sell; customers pay about 25 days after that; and suppliers themselves are paid at 217 days — netting out to the 13-day cycle.
In money terms: at FY26 sales of ₹88,512 Cr, each day of the cycle holds about ₹242 Cr — so the 13-day loop keeps roughly ₹3,152 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹55,721 Cr over the last 3 fiscal years against ₹11,804 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹8,276 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 13% and the ROIC − WACC spread is −2.3 pp.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
UltraTech Cement Ltd earns a ROCE of 13% in FY26. That is up from a trough of 10% in FY19. Return on invested capital clears the cost of that capital by −2.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 9.3% net margin on 0.63× asset turns.
FY26 ROCE is 13%, recovered from a FY19 trough of 10% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 9.3% net margin × 0.63× asset turns × 1.85× balance-sheet leverage ≈ 10.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.7% − 12.0% = a −2.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.31.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
UltraTech Cement Ltd carries total debt of ₹23,755 Cr against shareholder equity of ₹80,712 Cr as of Jun 26, a debt-to-equity of 0.29 — effectively unlevered. On the annual view that ratio went from 0.22 in FY22 to 0.29 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Jun 26: total debt of ₹23,755 Cr against shareholder equity of ₹80,712 Cr — a debt-to-equity of 0.29. On the annual view, debt-to-equity went from 0.22 (FY22) to 0.29 (FY26). The returns on this page are earned, not borrowed.
→ Who owns this, and are they adding or leaving? Next: Domestic institutions added 5.9 points over 8 quarters.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions added 5.9 points of UltraTech Cement Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 19.7% of the company. Foreign institutions moved −5.8 points over the same window, to 12.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +5.9 points over 8 quarters to 19.7%; Foreign institutions: −5.8 points over 8 quarters to 12.4%; Promoters: −0.6 points over 8 quarters to 59.3%.
Why the register moved: rotation — foreign institutions −5.8 points against domestic institutions +5.9 points over 8 quarters, with promoters −0.6 points — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
UltraTech Cement Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| UltraTech Cement Ltd this page | 40.5× | ₹3.5L Cr | Turning around | |||
| Ambuja Cements Ltd | 21.1× | ₹1.1L Cr | Improving | |||
| Shree Cement Ltd | 57.4× | ₹96,480 Cr | Turning around | |||
| J K Cements Ltd | 44.7× | ₹43,649 Cr | Mixed | |||
| Dalmia Bharat Ltd | 30.9× | ₹33,964 Cr | Mixed | |||
| ACC Ltd | 13.2× | ₹25,180 Cr | Mixed | |||
| The Ramco Cements Ltd | 730.0× | ₹21,616 Cr | Turning around | |||
| JSW Cement Ltd | 27.6× | ₹18,013 Cr | No read | |||
| Nuvoco Vistas Corporation Ltd | 30.6× | ₹12,717 Cr | Mixed | |||
| India Cements Ltd | 93.4× | ₹12,613 Cr | No read | |||
| Star Cement Ltd | 20.6× | ₹8,281 Cr | Turning around | |||
| Rain Industries Ltd | 25.1× | ₹7,576 Cr | No read | |||
| Birla Corporation Ltd | 13.2× | ₹7,367 Cr | Turning around | |||
| JK Lakshmi Cement Ltd | 17.9× | ₹7,107 Cr | Turning around | |||
| Prism Johnson Ltd | — | ₹5,437 Cr | No read | |||
| HeidelbergCement India Ltd | 25.4× | ₹3,544 Cr | Turning around | |||
| Orient Cement Ltd | 12.9× | ₹2,749 Cr | Mixed | |||
| Mangalam Cement Ltd | 18.5× | ₹2,706 Cr | No read | |||
| Sagar Cements Ltd | — | ₹2,321 Cr | No read | |||
| K C P Ltd | 10.4× | ₹2,097 Cr | Turning around | |||
| Shree Digvijay Cement Co. Ltd | 62.6× | ₹1,127 Cr | Turning around | |||
| NCL Industries Ltd | 6.4× | ₹835 Cr | No read | |||
| Deccan Cements Ltd | 43.4× | ₹776 Cr | — | No read | ||
| BIGBLOC Construction Ltd | — | ₹676 Cr | Turning around | |||
| Saurashtra Cement Ltd | 28.5× | ₹619 Cr | No read | |||
| Shiva Cement Ltd | — | ₹517 Cr | No read |
Frequently asked questions
What is UltraTech Cement Ltd's share price today?
UltraTech Cement Ltd trades at ₹11,727, −6.2% over the past year. The company is valued at ₹3,49,077 Cr. The stock sits at 47% of its 52-week range of ₹10,616–₹12,963, +0.1% versus its 200-day average. On the tape, the price is in a downtrend, 12 weeks in. — as of 24 July 2026.
What were UltraTech Cement Ltd's latest quarterly results?
UltraTech Cement Ltd reported revenue of ₹24,648 Cr and net profit of ₹2,604 Cr for the Jun 26 quarter. Revenue rose 15.9% and profit rose 17.2% year on year. Earnings per share were ₹88.21. The operating margin was 20.0%, 1.0 pp lower than a year earlier. — as of 24 July 2026.
What is UltraTech Cement Ltd's revenue?
UltraTech Cement Ltd reported revenue of ₹24,648 Cr in the Jun 26 quarter, +15.9% year on year. For the full FY26 fiscal year, revenue was ₹88,512 Cr (+16.5%). Over the last 10 years revenue compounded at 13.4% a year. — as of 24 July 2026.
What is UltraTech Cement Ltd's profit?
UltraTech Cement Ltd earned ₹2,604 Cr of net profit in the Jun 26 quarter, +17.2% year on year — the 6th straight quarter of growth. Full-year FY26 profit was ₹8,188 Cr. The operating margin ran 20.0% in the latest quarter. — as of 24 July 2026.
What is UltraTech Cement Ltd's market cap?
UltraTech Cement Ltd's market capitalisation is ₹3,49,077 Cr at a share price of ₹11,727. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is UltraTech Cement Ltd's P/E ratio?
UltraTech Cement Ltd trades at a P/E of 40.5×, at the 50th percentile of its own 10-year range, against a long-run median of 40.5×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does UltraTech Cement Ltd pay a dividend?
Yes — UltraTech Cement Ltd's dividend payout was 87% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is UltraTech Cement Ltd overvalued?
On its own history, UltraTech Cement Ltd looks mid-range against its own history: its P/E of 40.5× sits at the 50th percentile of its 10-year range (long-run median 40.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
Is UltraTech Cement Ltd growing?
Yes — UltraTech Cement Ltd is growing: latest-quarter revenue +15.9% year on year, profit +17.2%, and the margin −1.0 pp at 20.0%. The 10-year compound rates are 13.4% (revenue) and 12.7% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is UltraTech Cement Ltd performing?
UltraTech Cement Ltd is in a downtrend, 12 weeks in. Its latest quarter's revenue rose 15.9% and profit rose 17.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is UltraTech Cement Ltd in?
Mixed — the growth curves are steadily positive, but ROCE at 13.0% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +17.2% latest, profit growth +26.7% latest, eps growth +25.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is UltraTech Cement Ltd in an uptrend?
No — the price is in a downtrend (week 12 of stage 4), trading +0.1% versus its 200-day average and at 47% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is UltraTech Cement Ltd beating the market?
Not lately — on a trailing-13-week view UltraTech Cement Ltd is currently behind the NIFTY 500 (8 weeks and counting; last ahead the week of 2026-06-12), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +323% against the NIFTY 500's +280% — ahead of the index over the full window. — as of 24 July 2026.
Will UltraTech Cement Ltd's share price go up?
This page publishes no price forecast for UltraTech Cement Ltd. What it measures instead: the share price is ₹11,727, the price is in a downtrend 12 weeks in. Its P/E of 40.5× sits at the 50th percentile of its own 10-year range. — as of 24 July 2026.
Who owns UltraTech Cement Ltd?
Promoters hold 59.3% of UltraTech Cement Ltd, foreign institutions 12.4%, domestic institutions 19.7% and the public 8.4% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 5.9 points over 8 quarters. — as of 24 July 2026.
Does UltraTech Cement Ltd have too much debt?
It is moderate — UltraTech Cement Ltd's debt-to-equity is 0.31, and operating profit covers the interest bill 9×. FY26 borrowings were ₹23,755 Cr against equity of ₹76,624 Cr. Read the returns on this page with that leverage in mind — as of 24 July 2026.
What is UltraTech Cement Ltd's capex?
UltraTech Cement Ltd spent ₹55,721 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹11,382 Cr, with ₹8,276 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is UltraTech Cement Ltd's cash flow?
UltraTech Cement Ltd generated ₹15,316 Cr of operating cash flow in FY26 and ₹3,934 Cr of free cash flow after ₹11,382 Cr of capital spending. Reported profit that year was ₹8,188 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is UltraTech Cement Ltd's profit real cash?
Yes — over the last 3 fiscal years, 174% of UltraTech Cement Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹15,316 Cr against reported profit of ₹8,188 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is UltraTech Cement Ltd in its business cycle?
UltraTech Cement Ltd's FY26 operating margin was 19.0%, against a 13-year band of 17.0%–26.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 20.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the UltraTech Cement Ltd story?
The sharpest disagreement: annual EPS moved +35.2% against a −6.2% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is UltraTech Cement Ltd a stock worth studying right now?
This is not investment advice. The machine read: UltraTech Cement Ltd's earnings have outrun its stock. EPS grew +35.2% in a year against a −6.2% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.